Canadian Cancer Trials Group Bulletins

General


Dr. Ralph Meyer

Dear friends and colleagues,

It has been an enormous privilege to have had the opportunity to serve in a leadership role at Canadian Cancer Trials Group. I am deeply appreciative of the wisdom, sense of altruism and efforts that, as members of our investigative community, you have provided for our collective good. At a personal, level, I am very grateful for having experienced your support, wise council and friendship over these past seven years.

The cooperative group system plays a unique role in addressing research questions of societal interest and produces important answers that inform our health care policies and the next generation of research questions. Our Group's accomplishments are the result of combining the vision, curiosity and competencies of a high-quality national network of investigators with a superb research staff based in our Central Office. I know Elizabeth Eisenhauer, as Interim Director, and a new Director will experience the same excellent support and will provide leadership that forwards our mission and takes us to a new level of discovery.

Thank you so much for your contributions to our network and for the support that you have provided to me. With best wishes,

Yours sincerely,

Ralph M. Meyer, MD, FRCP(C)
Edith and Carla Eisenhauer Chair in Clinical Cancer Research
Director, Canadian Cancer Trials Group
Professor, Departments of Oncology, Medicine, and & Community Health and Epidemiology

Cancer Research Institute
10 Stuart St Queen's University Kingston, Ontario, K7L 3N6